Concepedia

François Charpentier

FC

Statistics

Publications

4

Citations

134

H-Index

4

Active since

1990

Affiliations

Établissement Français du Sang(Current)

Inserm

Institut Gustave Roussy

François Charpentier is an author at Établissement Français du Sang specializing in natural killer cell biology, natural killer cell-based cancer immunotherapy, and immunology.

Publications per year

1990–2020

4

Publications

4

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Thierry Hercend, F Farace, D Baume et al. · PubMed · 1990 · 58 citations

, , +15

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2

Bernard Escudier, F Farace, Eric Angevin et al. · European Journal of Cancer · 1994 · 54 citations

, , +16

Lessons learned from Paris and Nice

Stéphanie Noël, A. François, F. Le Failler et al. · ISBT Science Series · 2017 · 12 citations · Full text

, , +16

Noncompliance to blood donor selection criteria by men who have sex with men – Complidon 2017, France

Claire Sauvage, François Charpentier, E. Garrabé et al. · Vox Sanguinis · 2020 · 10 citations

, , +14

1–4 of 4